Abstract | OBJECTIVE: DESIGN: Retrospective study. SETTING: Mayo Clinic. PATIENTS: Between January 1, 1999, and September 30, 2010, 553 patients underwent pancreaticoduodenectomy by a single surgeon. MAIN OUTCOME MEASURES: Rates of POPF, morbidity, and mortality between stent and no- stent groups. RESULTS: The clinically relevant POPF (International Study Group on Pancreatic Fistula definition grade B or C) rates in the stent and no- stent groups were similar (9.6% [43 of 449 patients] and 12.5% [13 of 104 patients], respectively; P = .38). Postoperative outcomes and morbidity were also similar between the 2 groups. Mortality was 0.7% (3 of 449 patients) for the stent group and 1.0% (1 of 104 patients) for the no- stent group. Four patients (0.9%) required endoscopic retrieval of the anastomotic stent. In subset analysis, the clinically relevant POPF rates in patients with a small pancreatic duct (≤3 mm; n = 167) were similar in the stent and no- stent groups (17.7% [23 of 130 patients] and 24.3% [9 of 37 patients], respectively; P = .38). In patients with a soft pancreatic gland (n = 64), rates of clinically relevant pancreatic fistulae were also similar in the stent and no- stent groups (31.7% [13 of 41 patients] and 17.4% [4 of 23 patients], respectively; P = .20). CONCLUSIONS: Internal transanastomotic pancreatic duct stenting does not decrease the frequency or severity of POPF. The effect of stenting on long-term anastomotic patency warrants further investigation.
|
Authors | Toshiyuki Moriya, Clancy J Clark, Yujiro Kirihara, Michael L Kendrick, Kaye M Reid Lombardo, Florencia G Que, Michael B Farnell |
Journal | Archives of surgery (Chicago, Ill. : 1960)
(Arch Surg)
Vol. 147
Issue 1
Pg. 35-40
(Jan 2012)
ISSN: 1538-3644 [Electronic] United States |
PMID | 22250109
(Publication Type: Journal Article)
|
Topics |
- Aged
- Female
- Humans
- Male
- Middle Aged
- Pancreatic Fistula
(epidemiology, etiology, prevention & control)
- Pancreaticoduodenectomy
(adverse effects, methods)
- Retrospective Studies
- Stents
|